News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
- Our Cancer Program at Northwestern Memorial Hospital Ranked #6 in the Nation by U.S. News & World Report07.27.2021
Lurie Cancer Center at Northwestern Memorial Hospital is ranked No. 6 in the nation by U.S. News & World Report in its 2021-2022 list of Best Hospitals for Cancer, and recognized once again as the top Cancer program in Illinois and Chicago.
Patricia Hoffman had never been sick a day in her life. She never thought she would get involved in research either, or be able to give back philanthropically. But, as she said, “life will throw you surprises.”
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
A Northwestern Medicine study has found that women with hormone receptor-positive breast cancer were more likely to discontinue hormone therapy early due to poor quality of life-related outcomes.
A scholarship for future leaders in neurosurgery honors the life of Maureen Rogan.
Seth Pollack, MD, a renowned expert on immunotherapy strategies, is the new director of Lurie Cancer Center’s Sarcoma Program.
Luisa Iruela-Arispe, PhD, an internationally recognized vascular biologist, has been named co-leader of the Tumor Environment and Metastasis (TEAM) Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
On Sunday, June 6, our 28th Annual Cancer Survivors’ Celebration & Walk brought us together, virtually, to celebrate milestones, advance life-changing research, and honor those who have faced or are facing cancer.
A drug currently used to prevent organ rejection in transplants could also reduce chemotherapy resistance in glioblastoma, according to a Northwestern Medicine study.
In 1991, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University was dedicated through a gift of endowment from Ann and Robert H. Lurie. We proudly commemorate and recognize this important date in Lurie Cancer Center’s history by celebrating the 30th anniversary of its naming throughout the year 2021.
Northwestern Medicine scientists have described a method of reconstructing the three-dimensional structure of chromosomes in cancer cells and matching those chromosomes with counterpart oncogenes.
For the first time, scientists have examined how the three-dimensional structure of chromatin can play a part in the development of bladder cancer and pediatric brain tumors, according to a pair of Northwestern Medicine studies.
Using small molecular inhibitors to block the BAP1 complex may be a promising targeted therapy approach for leukemia, according to a Northwestern Medicine study published in Nature Cancer.
Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss cutting-edge clinical research during the 2021 ASCO Annual Meeting, taking place online June 4 – 8
Every year, on May 20, Clinical Trials Day is celebrated around the world. COVID-19 made 2020 an extraordinary and challenging time – but clinical investigators rose to the challenge. Thanks to clinical trials, millions of doses of life-saving vaccines have been developed and administered around the world, giving reason to hope for a better year ahead.
- Lurie Cancer Center and other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track05.20.2021
The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.
Two Northwestern Medicine studies are improving the understanding of epigenetic mechanisms in cancer development and progression, and identifying novel cancer driver genes that may help identify patients who will benefit from immunotherapy.
WGN anchor, two-time cancer survivor, wife, mother of four, avid fundraiser, medical reporter, and science enthusiast DINA BAIR is on a mission to create awareness and raise funds for Robert H. Lurie Cancer Survivorship Institute.
See more news in the article archive.